Multimodal pain management: building a plan that fits.

Medication, rehabilitation, and psychological support can each have a place in pain care. The useful question is how they fit together in your life.

You might have a prescription from one clinician, exercises from another, and advice about sleep from a third. Each recommendation may make sense on its own. Fitting all of them into a working week is another matter.

In Stanford Medicine's Management of Chronic Pain: Getting to the Root of Persistent Pain, Sean Mackey describes several approaches to care. Our reading of the talk is that the choices need to work together. A longer treatment list is useful only if someone helps you decide what belongs on it.

What can a multimodal plan include?

Mackey groups treatment into six broad areas around 33:48 in the talk. Think of them as options to discuss, rather than six tasks you must complete. Some treatments suit particular conditions, and some will not suit you at all.

The aim is to make a manageable plan with a reason for each part. If appointments, travel, cost, or fatigue make that plan impossible, those are problems to solve together. They should not be treated as a lack of commitment.

Multimodal, multidisciplinary, and postoperative care

Multimodal describes the combination of approaches. Multidisciplinary describes the involvement of clinicians from different professions. Terminology varies, so ask how a particular service works. Stanford's Pain Management Center, for example, describes coordinated care involving pain specialists, psychologists, rehabilitation clinicians, physical therapists, and social workers.

You may also encounter the term multimodal analgesia in advice about surgery. UCSF's explanation focuses on combining approaches to postoperative pain relief while limiting opioid exposure. That setting has its own prescribing decisions. A hospital pain regimen is not a set of instructions to copy at home for persistent pain.

Why can pain need more than one kind of treatment?

Pain can involve ongoing illness or injury, changes in nerve function, and changes in how the nervous system processes signals. It can also affect sleep, mood, movement, and relationships. NINDS describes these interacting aspects of pain and notes that persistent pain can continue after an initial cause has resolved or occur without a known cause.

This helps explain why a clinician may ask about several parts of your life. It does not make your pain imaginary. The International Association for the Study of Pain emphasizes both the personal nature of pain and the importance of respecting the person's report.

In our view, “getting to the root” should mean asking careful questions about what might be contributing. It should leave room for more than one explanation and for uncertainty. An app cannot identify the cause from a chat or a reassuring device reading. Our pain neuroscience commentary explores how to explain pain without closing off further assessment.

Does combining treatments improve chronic pain?

A 2021 review commissioned by AHRQ examined 57 randomized trials of integrated or comprehensive pain-management programs. Compared with usual care or a waiting list, some programs produced small improvements in pain and small to moderate improvements in function. Results varied by program and follow-up period, and benefits were not consistently maintained over longer follow-up.

The review also found limited evidence about harms and about which program components accounted for outcomes. It supports considering coordinated care, while leaving substantial uncertainty about the best combination for an individual. It does not establish that adding more treatments always helps, or that an AI companion can reproduce a clinical program's results.

What should your care plan make clear?

A useful plan gives you enough information to decide what to try and what to do if it is not helping. NICE's chronic pain guidance calls for assessment and a shared care plan that takes the person's priorities and circumstances into account.

• A goal you recognize. Perhaps you want more comfortable evenings, fewer medication side effects, or enough energy to visit someone. Pain relief can remain a goal alongside those changes.
• A reason for each treatment. Ask what it is intended to change and when you will review whether it has helped.
• Someone who keeps the plan together. Know who to contact when recommendations conflict or a treatment is causing problems.
• Room to adapt. Tell the team what the plan costs you in time, money, energy, and symptoms. Agree what can be changed or stopped safely.

For a practical way to prepare those conversations, see what to expect at your first pain-management appointment.

Two parts of the older talk need particular care

Mackey encourages gradual increases in activity. That advice needs to be matched to the person's condition. In ME/CFS, NICE advises against fixed incremental increases in exercise. If activity causes delayed worsening, bring that pattern to your clinician rather than treating it as something you must push through.

The talk also discusses medication choices in the context of 2016. It is not a current prescribing guide. Decisions about starting, changing, or stopping medication belong with your prescriber. CDC guidance emphasizes weighing benefits and risks with the patient and avoiding abrupt opioid discontinuation except in circumstances such as a life-threatening emergency. A broader care plan should not become a reason to withdraw medication without that discussion.

What to take from Sean Mackey's talk

Stanford Medicine published this recording on June 1, 2016. We reviewed its full English auto-generated captions, including the Q&A, and inspected selected video segments and slides. This is an editorial interpretation, with later sources used to check the clinical implications.

• Around 14:57: Mackey distinguishes nociception from the experience of pain.
• Around 27:15: he urges clinicians to ask about a person's pain rather than judge it against their own experience.
• Around 33:48: he sets out the treatment approaches discussed above.
• Around 42:33: he encourages discussion of hopes, daily activities, and treatment expectations.

The Q&A includes emerging ideas about virtual reality. Mackey is explicit about uncertainty over its mechanisms. That distinction matters for Cindra: an interesting research direction is a reason to investigate, not evidence that our product works.

Where Cindra could help

For the companion we are building, a useful role would be helping someone keep track of questions, describe what changed between visits, and remember the goals they chose. Those are proposals, not verified features or demonstrated clinical benefits. Any summary should be checked by the person before it is shared. Diagnosis, prescribing, and decisions about procedures belong with the clinical team.

Educational commentary and proposed product requirements. Sources checked October 27, 2026. This article has not undergone clinical review and does not provide an individualized care plan. Cindra requires product-specific evaluation before clinical benefit can be claimed.